PHP193 Paediatric Use Marketing Authorisation (PUMA)- The Challenges of Cost-Effectiveness Modelling Where Limited Clinical Trial Information is Available
Abstract
Authors
D. Gladwell D. Lee E. Tate A. Batty N.J. Brereton
D. Gladwell D. Lee E. Tate A. Batty N.J. Brereton
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now